5 Clinical Trial Data Collection Mistakes Small Teams Keep Repeating

Clean clinical trial data starts before the first record is entered. Small teams avoid most data collection mistakes by defining variables from the protocol, using structured field types instead of free text, adding validation before enrollment, assigning clear data ownership, and testing exports with fake records before the study goes live.

That sounds obvious until the study is halfway done and the team discovers five versions of the same site name, dates stored as text, repeated events trapped in notes fields, and an export that cannot answer the endpoint question without a cleanup spreadsheet. The damage usually comes from small workflow choices made early.

Here are the five mistakes small clinical research teams keep repeating, and how to prevent them without turning the study setup into an enterprise implementation project.

1. Collecting data before the variables are defined

The first mistake is treating the CRF as the starting point.

The CRF is not the starting point. The protocol is. More specifically, the endpoint questions are.

Before anyone builds a form, the team should write a simple data dictionary. It does not need to be fancy. It needs to answer practical questions:

• What variable are we collecting?
• Why do we need it?
• Where does it come from?
• What type of value should it hold?
• What units or allowed options are acceptable?
• Is “unknown,” “not done,” or “not applicable” a valid answer?
• Where will the variable appear in the final export?

Without that map, teams build forms around habit. They copy last year’s spreadsheet. They add fields because someone asked for them in a meeting. They leave ambiguous labels because everyone “knows what it means” during setup.

Six months later, nobody knows what it meant.

A cleaner workflow starts with endpoints, eligibility criteria, visit windows, safety variables, and planned analyses. Each required variable gets a field name, a label, a type, and a source. If the study needs 30-day complication status, the database needs a clear 30-day follow-up field. If the study needs age at procedure, the database needs the input dates or a calculated value, not a hand-typed note.

A clinical trial database is not a storage folder. It is the structure that protects the protocol question.

2. Using free text for data that should be structured

Free text is useful for comments, protocol deviations, and clinical nuance. It is a terrible default for data that needs to be counted, filtered, validated, or analyzed.

Small teams fall into this trap because free text feels fast. A coordinator can type anything. The form is easy to build. No one has to argue about allowed values.

The bill arrives later.

You get “male,” “M,” “m”, and “Man” in the same column. You get “Barcelona,” “BCN,” and a hospital name mixed into the site field. You get dates written in different formats. You get adverse events described in paragraphs when the analysis needs grade, seriousness, start date, resolution date, and relationship to intervention as separate variables.

Use the narrowest field type that fits the question.

Trialinx supports 13 field types in its form builder: text, textarea, number, date, date range, select, multi-select, radio buttons, checkbox, checkbox group, repeater, calculated fields, and markdown display fields. That range matters because clinical data is not one shape. A study may need dates, numeric lab values, repeated medications, controlled categories, calculated scores, and short instructions inside the same workflow.

A few practical rules help:

• use number fields for values you may calculate or compare
• use date fields for dates, not typed text
• use select or radio fields for fixed categories
• use checkbox groups when several yes/no options travel together
• use repeaters for repeated structures such as medications, adverse events, specimens, lesions, or visits
• use calculated fields when the value should come from other entries
• use markdown display fields for protocol guidance, not captured data

If the platform forces structured clinical data into notes fields, the team will rebuild that structure by hand during cleaning. That is avoidable work.

3. Adding validation after the study has already started

Validation rules are most useful at the moment of data entry, while the coordinator still has the source document open.

Too many teams treat validation as a late quality-control step. They collect data first, then run checks after dozens or hundreds of records exist. By then, every fix requires backtracking: find the source, ask the site, interpret the note, correct the value, document the change.

Good validation catches boring mistakes early.

Examples:

• required fields for core endpoint variables
• plausible ranges for numeric values
• fixed options for study arm, site, status, or grade
• date rules that prevent follow-up before baseline
• conditional logic that shows extra fields only when they apply
• clear missing-data options when the source does not contain the answer

Trialinx supports conditional visibility with five comparison operators: equals, not equals, contains, greater than, and less than. That lets a team keep forms shorter without losing structure. If an adverse event is marked serious, additional seriousness criteria can appear. If a screening criterion is not met, an ineligibility reason can appear. If a follow-up visit was not completed, fields about the visit do not need to clutter the form.

The point is not to block coordinators with rigid forms. The point is to catch preventable errors when they are cheap to fix.

There is one warning: required fields are not a substitute for judgment. If the source record may not contain a value, forcing an answer can create fake precision. “Unknown” is better than a guessed value. “Not applicable” is better than a blank note explaining why the field could not be completed.

4. Leaving ownership and audit expectations vague

Clinical data collection is team work. That is exactly why ownership needs to be explicit.

Small teams often start with informal roles. One person builds the forms. Another enters data. A statistician asks for exports. A PI reviews records. Someone else changes a dropdown because a site asked for a new option.

That can work for ten records. It gets messy when the study grows.

Before the first live subject, decide who owns each part of the data workflow:

• who can edit forms
• who can publish form changes
• who can enter subject records
• who can review or sign records
• who can export data
• who can invite collaborators
• who reviews change history when something looks wrong

Trialinx uses study roles for collaboration, including viewer, collaborator, and manager. The exact role setup should match the study workflow. A statistician may need export access but not form-editing access. A site coordinator may need to enter data but not change the CRF design. A manager may need to review changes across the study.

Auditability matters here, but it should not be treated as magic. Trialinx tracks audit events across study entities with user, study, entity, action, IP address, user agent, timestamp, and old/new values. That record helps the team answer “who changed what and when?” It still needs a study SOP or operating rule that says which changes require review and who handles them.

Vague ownership creates two bad outcomes: people make changes they should not make, or nobody makes changes because everyone assumes someone else owns the problem.

Clear roles are cheaper.

5. Waiting too long to test the export

The final mistake is the most painful one: teams test the database by looking at the forms, not the output.

A form can look clean and still produce a bad dataset.

Before enrollment starts, enter fake records that represent real edge cases. Include normal subjects, screen failures, missing values, adverse events, repeated visits, serious events, protocol deviations, and unusual but plausible values. Then export the data and inspect it like an analyst would.

Ask direct questions:

• Can the primary endpoint be calculated from the export?
• Do field names make sense outside the platform?
• Are dates and numbers exported in usable formats?
• Do repeated sections preserve their relationship to the subject and visit?
• Are missing values distinguishable from unanswered fields?
• Are calculated fields behaving as expected?
• Can the statistician use the file without a manual rescue step?

This pilot run is where teams find problems while the database is still easy to change. A confusing label costs almost nothing to fix before launch. It becomes expensive after hundreds of records use it.

Exports also expose hidden spreadsheet habits. If a field mixes units, comments, and numeric values, the export will show it. If repeated data was stuffed into one text field, the export will show it. If a dropdown has overlapping options, the export will show it.

Trialinx enables data export on the Professional plan, and small teams can check the current limits on the pricing page. Teams that want to see the data workflow before committing can use the demo and compare it against one real study design.

A better data collection workflow for small teams

A good clinical trial data collection workflow is boring in the right places.

Define the variable before the field. Use a structured field type when the answer needs structure. Add validation before live data entry. Set roles before inviting the team. Test exports before the first subject.

That sequence prevents the problems that make small teams lose weeks to cleanup: ambiguous labels, inconsistent categories, fake free-text flexibility, unclear ownership, and datasets that do not match the protocol question.

If your team is moving from spreadsheets or a legacy workflow, do not try to fix everything at once. Pick one study. Build the data dictionary. Create the CRFs. Enter fake records. Review the export. Then decide what needs to change before the study goes live.

The Trialinx FAQ covers common setup questions, and teams with a specific data collection problem can contact Trialinx. If the workflow fits, start with one study and test it against the mistakes above.